Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 1/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | USP2 | O75604 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.36 |
| ▸ | KCNH3 | Q9ULD8 | 1/20 | 0.35 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.33 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | GLS | O94925 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20878209 | 0.92 | ALDH1A1 (0.86) | ALDH1A1CYP3A4ALOX15TDP1USP2 | |
| SCHEMBL5804490 | 0.84 | — | — | |
| SCHEMBL7093157 | 0.84 | ALDH1A1 (0.70) | ALDH1A1CYP3A4ALOX15TDP1USP2 | |
| SCHEMBL7094868 | 0.82 | ALDH1A1 (0.67) | ALDH1A1CYP3A4ALOX15TDP1USP2 | |
| SCHEMBL16153546 | 0.81 | ALDH1A1 (0.68) | ALDH1A1CYP3A4ALOX15TDP1USP2 | |
| SCHEMBL16146034 | 0.81 | ALDH1A1 (0.68) | ALDH1A1CYP3A4ALOX15TDP1USP2 | |
| SCHEMBL16146035 | 0.81 | ALDH1A1 (0.68) | ALDH1A1CYP3A4ALOX15TDP1USP2 | |
| SCHEMBL11060991 | 0.77 | ALDH1A1 (0.61) | ALDH1A1CYP3A4ALOX15TDP1USP2 | |
| SCHEMBL3392080 | 0.76 | ALDH1A1 (0.67) | ALDH1A1CYP3A4ALOX15TDP1USP2 | |
| SCHEMBL3389147 | 0.76 | ALDH1A1 (0.67) | ALDH1A1CYP3A4ALOX15TDP1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260034186-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2026-02-05 | — | — | US | disclosed |
| US-20260027136-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | YUZU LV LLC (US) | 2026-01-29 | — | — | US | disclosed |
| US-12458653-B2 | Cannabis based therapeutic and method of use | YUZU LV LLC (US) | 2025-11-04 | — | — | US | disclosed |
| US-12427176-B2 | Enriched mineral pitch resin products and methods of manufacturing enriched mineral pitch resin products | RIZUN NODARI (US) | 2025-09-30 | — | — | US | disclosed |
| US-12303488-B2 | Cannabis based therapeutic and method of use | YUZU LV LLC (US) | 2025-05-20 | — | — | US | disclosed |
| WO-2024263996-A2 | COMPOUNDS AND METHODS FOR TREATING AGAINST NEMATODE INFECTIONS AND METHODS FOR COMPOUND DISCOVERY FOR SAME | NEW YORK UNIVERSITY (US) | 2024-12-26 | — | — | WO | disclosed |
| EP-4417252-A2 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | Yuzu LV LLC (US) | 2024-08-21 | — | — | EP | disclosed |
| US-20240216457-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2024-07-04 | — | — | US | disclosed |
| US-20240216456-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2024-07-04 | — | — | US | disclosed |
| US-20240207344-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2024-06-27 | — | — | US | disclosed |
| US-7589121-B2 | Use of furan alkyls for preparing a drug for treating obesity and cosmetically treating overweight | LABORATOIRES EXPANSCIENCE (FR) | 2009-09-15 | — | — | US | disclosed |
| US-20080219937-A1 | purified furanic fraction of unsaponifiable of avocado, used for reducing, eliminating or preventing pigment spots, on the skin of a person | LABORATOIRES EXPANSCIENCE (FR) | 2008-09-11 | — | — | US | disclosed |
| US-20080219937-A1 | purified furanic fraction of unsaponifiable of avocado, used for reducing, eliminating or preventing pigment spots, on the skin of a person | LABORATOIRES EXPANSCIENCE (FR) | 2008-09-11 | — | — | US | disclosed |
| US-20080081837-A1 | Reducing glucose blood concentration and increasing tolerance with unsaponifiable avocado extract | LABORATOIRES EXPANSCIENCE | 2008-04-03 | — | — | US | disclosed |
| US-20080081837-A1 | Reducing glucose blood concentration and increasing tolerance with unsaponifiable avocado extract | LABORATOIRES EXPANSCIENCE | 2008-04-03 | — | — | US | disclosed |
| US-20070281994-A1 | Use Of Furan Alkyls For A Cellulite Cosmetic Treatment | LABORATOIRES EXPANSCIENCE | 2007-12-06 | — | — | US | disclosed |
| US-20070281994-A1 | Use Of Furan Alkyls For A Cellulite Cosmetic Treatment | LABORATOIRES EXPANSCIENCE | 2007-12-06 | — | — | US | disclosed |
| US-20070238777-A1 | Use of Furan Alkyls for Preparing a Drug for Treating Obesity and Cosmetically Treating Overweight | LABORATOIRES EXPANSCIENCE | 2007-10-11 | — | — | US | disclosed |
| US-20070238777-A1 | Use of Furan Alkyls for Preparing a Drug for Treating Obesity and Cosmetically Treating Overweight | LABORATOIRES EXPANSCIENCE | 2007-10-11 | — | — | US | disclosed |
| US-6133313-A | SPECIFIED AVOCADOFURANS SUCH AS 2-(TETRADECYL)FURAN, 2-(PENTADECYL)FURAN, 2-(HEXADECYL)FURAN, 2-(HEPTADECYL)FURAN, 2-(OCTADECYL)FURAN, 2-(1E-PENTADECENYL)FURAN, DERIVED FROM IDIOBLAST OIL CELLS OF AVOCADO; CONTROLLING SPODOPTERA EXIGUA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2000-10-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070238777-A1 | Use of Furan Alkyls for Preparing a Drug for Treating Obesity and Cosmetically Treating Overweight | ACSL5, FASN, MC5R | ALDH1A1 129/4885CYP3A4 223/4885ALOX15 26/4885 |
| US-20080219937-A1 | purified furanic fraction of unsaponifiable of avocado, used for reducing, eliminating or preventing pigment spots, on the skin of a person | TYR, APEH, ALAD | ALDH1A1 64/4885CYP3A4 1457/4885ALOX15 19/4885 |
| US-20070281994-A1 | Use Of Furan Alkyls For A Cellulite Cosmetic Treatment | ACSL5, FASN, CUTA | ALDH1A1 747/4885CYP3A4 1011/4885ALOX15 39/4885 |
| US-20260027136-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | CNR1, CNR2, OPRM1 | ALDH1A1 1420/4885CYP3A4 1136/4885ALOX15 11/4885 |
| US-20260034186-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | TRPV1, SOST, RUNX1 | ALDH1A1 4768/4885CYP3A4 1979/4885ALOX15 121/4885 |
| US-20080081837-A1 | Reducing glucose blood concentration and increasing tolerance with unsaponifiable avocado extract | FOS, IRS1, GPR119 | ALDH1A1 1153/4885CYP3A4 567/4885ALOX15 130/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.